NFL Biosciences is a biotech which develops botanical drugs for the treatment of dependencies and addictions.
Business Model:
Revenue: $0
Employees: 1-10
Address: 199 rue Helene Boucher
City: Castelnau-le-Lez
State: other
Zip: 34170
Country: FR
Contact Phone:
Contact Email:
Listed Exchange:
NYSE Euronext
IPO Date:
7/5/2021
Ticker Symbol:
ALNFL
IPO Price:
$4.5088872540876626/share
Amount Raised:
$6M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2023 | Private Placement | $3.3M | 7/2021 | IPO | - | 1/2023 | Grant | 2 | $217.2k |
Bpifrance Occitanie Angels Bpifrance Occitanie Angels |
1/2023 | Post-IPO Equity | $3.3M | 7/2021 | IPO | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|